1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Erythropoietin Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Drug Class
6.1 Biologics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Biosimilars
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Product Type
7.1 Epoetin-alfa
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Epoetin-beta
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Darbepoetin-alfa
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Application
8.1 Hematology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Kidney Disorder
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Cancer
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Homecare
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Specialty Clinics
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Amgen Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Biocon Limited
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Dr. Reddy’s Laboratories Ltd.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 F. Hoffmann-La Roche AG
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.5 Intas Pharmaceuticals Ltd.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Johnson & Johnson
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 LG Chem Ltd.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Pfizer Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Sun Pharmaceutical Industries Limited
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Teva Pharmaceutical Industries Ltd.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
List of Figures
Figure 1: Global: Erythropoietin Drugs Market: Major Drivers and Challenges
Figure 2: Global: Erythropoietin Drugs Market: Sales Value (in Billion USD), 2018-2023
Figure 3: Global: Erythropoietin Drugs Market Forecast: Sales Value (in Billion USD), 2024-2032
Figure 4: Global: Erythropoietin Drugs Market: Breakup by Drug Class (in %), 2023
Figure 5: Global: Erythropoietin Drugs Market: Breakup by Product Type (in %), 2023
Figure 6: Global: Erythropoietin Drugs Market: Breakup by Application (in %), 2023
Figure 7: Global: Erythropoietin Drugs Market: Breakup by End User (in %), 2023
Figure 8: Global: Erythropoietin Drugs Market: Breakup by Region (in %), 2023
Figure 9: Global: Erythropoietin Drugs (Biologics) Market: Sales Value (in Million USD), 2018 & 2023
Figure 10: Global: Erythropoietin Drugs (Biologics) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 11: Global: Erythropoietin Drugs (Biosimilars) Market: Sales Value (in Million USD), 2018 & 2023
Figure 12: Global: Erythropoietin Drugs (Biosimilars) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 13: Global: Erythropoietin Drugs (Epoetin-alfa) Market: Sales Value (in Million USD), 2018 & 2023
Figure 14: Global: Erythropoietin Drugs (Epoetin-alfa) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 15: Global: Erythropoietin Drugs (Epoetin-beta) Market: Sales Value (in Million USD), 2018 & 2023
Figure 16: Global: Erythropoietin Drugs (Epoetin-beta) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 17: Global: Erythropoietin Drugs (Darbepoetin-alfa) Market: Sales Value (in Million USD), 2018 & 2023
Figure 18: Global: Erythropoietin Drugs (Darbepoetin-alfa) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 19: Global: Erythropoietin Drugs (Other Product Types) Market: Sales Value (in Million USD), 2018 & 2023
Figure 20: Global: Erythropoietin Drugs (Other Product Types) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 21: Global: Erythropoietin Drugs (Hematology) Market: Sales Value (in Million USD), 2018 & 2023
Figure 22: Global: Erythropoietin Drugs (Hematology) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 23: Global: Erythropoietin Drugs (Kidney Disorder) Market: Sales Value (in Million USD), 2018 & 2023
Figure 24: Global: Erythropoietin Drugs (Kidney Disorder) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 25: Global: Erythropoietin Drugs (Cancer) Market: Sales Value (in Million USD), 2018 & 2023
Figure 26: Global: Erythropoietin Drugs (Cancer) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 27: Global: Erythropoietin Drugs (Other Applications) Market: Sales Value (in Million USD), 2018 & 2023
Figure 28: Global: Erythropoietin Drugs (Other Applications) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 29: Global: Erythropoietin Drugs (Hospitals) Market: Sales Value (in Million USD), 2018 & 2023
Figure 30: Global: Erythropoietin Drugs (Hospitals) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 31: Global: Erythropoietin Drugs (Homecare) Market: Sales Value (in Million USD), 2018 & 2023
Figure 32: Global: Erythropoietin Drugs (Homecare) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 33: Global: Erythropoietin Drugs (Specialty Clinics) Market: Sales Value (in Million USD), 2018 & 2023
Figure 34: Global: Erythropoietin Drugs (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 35: Global: Erythropoietin Drugs (Other End Users) Market: Sales Value (in Million USD), 2018 & 2023
Figure 36: Global: Erythropoietin Drugs (Other End Users) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 37: North America: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 38: North America: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 39: United States: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 40: United States: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 41: Canada: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 42: Canada: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 43: Asia-Pacific: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 44: Asia-Pacific: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 45: China: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 46: China: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 47: Japan: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 48: Japan: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 49: India: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 50: India: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 51: South Korea: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 52: South Korea: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 53: Australia: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 54: Australia: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 55: Indonesia: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 56: Indonesia: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 57: Others: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 58: Others: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 59: Europe: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 60: Europe: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 61: Germany: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 62: Germany: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 63: France: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 64: France: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 65: United Kingdom: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 66: United Kingdom: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 67: Italy: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 68: Italy: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 69: Spain: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 70: Spain: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 71: Russia: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 72: Russia: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 73: Others: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 74: Others: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 75: Latin America: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 76: Latin America: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 77: Brazil: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 78: Brazil: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 79: Mexico: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 80: Mexico: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 81: Others: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 82: Others: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 83: Middle East and Africa: Erythropoietin Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 84: Middle East and Africa: Erythropoietin Drugs Market: Breakup by Country (in %), 2023
Figure 85: Middle East and Africa: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 86: Global: Erythropoietin Drugs Industry: SWOT Analysis
Figure 87: Global: Erythropoietin Drugs Industry: Value Chain Analysis
Figure 88: Global: Erythropoietin Drugs Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Erythropoietin Drugs Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Erythropoietin Drugs Market Forecast: Breakup by Drug Class (in Million USD), 2024-2032
Table 3: Global: Erythropoietin Drugs Market Forecast: Breakup by Product Type (in Million USD), 2024-2032
Table 4: Global: Erythropoietin Drugs Market Forecast: Breakup by Application (in Million USD), 2024-2032
Table 5: Global: Erythropoietin Drugs Market Forecast: Breakup by End User (in Million USD), 2024-2032
Table 6: Global: Erythropoietin Drugs Market Forecast: Breakup by Region (in Million USD), 2024-2032
Table 7: Global: Erythropoietin Drugs Market: Competitive Structure
Table 8: Global: Erythropoietin Drugs Market: Key Players